These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 1507405
21. A pharmacodynamic model to support a 12-hour dosing interval for amoxicillin/sulbactam, a novel oral combination, in the treatment of community-acquired lower respiratory tract infections. Bantar C, Nicola F, Fernandez Canigia L, Arenoso HJ, Soutric J, Montoto M, Blanco M, Smayevsky J, Jasovich A. J Chemother; 2000 Jun; 12(3):223-7. PubMed ID: 10877517 [Abstract] [Full Text] [Related]
27. [Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The viewpoint of the pediatrician]. de Blic J. Presse Med; 1998 Sep; 27 Suppl 4():16-7. PubMed ID: 9798479 [No Abstract] [Full Text] [Related]
28. [Pharmacokinetic, bacteriological and clinical studies on meropenem in children]. Tajima T, Negishi S, Kondo Y, Nishimura S, Higa A, Hagiwara N, Niimi R, Kawashima S, Abe T. Jpn J Antibiot; 1992 Jul; 45(7):826-32. PubMed ID: 1522674 [Abstract] [Full Text] [Related]
33. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000]. Melo-Cristino J, Fernandes ML, Serrano N, Grupo de Estudo Português de Bactérias Patogénicas Respiratórias. Acta Med Port; 2001 Jul; 14(5-6):459-68. PubMed ID: 11878155 [Abstract] [Full Text] [Related]
34. [Clinical evaluation of a new carbapenem, meropenem, in infants and children]. Meguro H, Mori A, Fujii R, Terashima I, Kurosaki T, Toba T, Nakamura A, Suzuki H, Niimi H. Jpn J Antibiot; 1992 Jul; 45(7):866-79. PubMed ID: 1522678 [Abstract] [Full Text] [Related]